Prostate cancer is rapidly becoming one of the most prevalent malignancies amongst men globally. While historically less common across South Asia, Bangladesh is currently witnessing a steady escalation in cases. This shift is largely driven by increased life expectancy, the pressures of urbanisation, sedentary dietary habits, and improved diagnostic protocols. However, a significant question remains: is the national healthcare infrastructure sufficiently prepared to manage this growing clinical burden?
Diagnostic Progress and Current Limitations
Over the last decade, Bangladesh has achieved commendable milestones in oncology diagnostics. The Prostate-Specific Antigen (PSA) blood test is now widely accessible, even in various district towns. Furthermore, many urban hospitals have adopted multi-parametric MRI (mpMRI)—a gold standard for staging the disease—alongside TRUS-guided biopsies and advanced histopathology services.
Despite these advancements, high-end care remains predominantly centralised in metropolitan hubs. A lack of awareness in rural communities, coupled with the absence of a routine screening culture, means many patients present only when the disease is advanced. Critically, the availability of PSMA PET-CT scans—which have revolutionised the detection of cancer recurrence and precise staging—remains extremely limited. Without accurate staging, formulating an effective, personalised treatment plan is immensely challenging.
Identifying the Red Flags
Early detection is the cornerstone of successful treatment. As the risk increases with age, it is vital for men to remain vigilant.
| Symptom Category | Specific Indicators |
| Urinary Habits | Hesitancy, weak flow, or a feeling that the bladder hasn’t fully emptied. |
| Nocturnal Changes | Frequent need to urinate during the night (Nocturia). |
| Visible Alarms | Hematuria (blood in the urine) or blood in the semen. |
| Pain & Pressure | Persistent discomfort in the pelvic area or lower abdomen. |
| Advanced Signs | Unexplained bone pain, particularly localized in the spine or hips. |
The Therapeutic Frontier
Radiotherapy has emerged as a highly effective intervention for prostate cancer. By utilizing modern Linear Accelerators (LINAC), clinicians can deliver high-dose radiation to the tumour while sparing surrounding healthy tissue. Techniques such as Image-Guided Radiotherapy (IGRT) and hypofractionation—which reduces the total number of treatment sessions—are gradually becoming more common, thereby easing the patient’s journey.
However, infrastructure remains a bottleneck. Public hospitals are plagued by long waiting lists due to a shortage of machinery. Moreover, there is a palpable deficit of skilled radiation oncologists, medical physicists, and technologists. Cutting-edge treatments like Stereotactic Body Radiotherapy (SBRT) are currently confined to a handful of elite centres, highlighting the need for broader investment in adaptive planning and real-time motion management technologies.